BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19318668)

  • 1. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
    William WN; Lin HY; Lee JJ; Lippman SM; Roth JA; Kim ES
    Chest; 2009 Sep; 136(3):701-709. PubMed ID: 19318668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.
    Zell JA; Ignatius Ou SH; Ziogas A; Anton-Culver H
    J Thorac Oncol; 2007 Dec; 2(12):1078-85. PubMed ID: 18090578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The revised TNM staging system for lung cancer.
    Rami-Porta R; Crowley JJ; Goldstraw P
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
    Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
    Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
    Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
    J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems related to TNM staging: patients with stage III non-small cell lung cancer.
    Kameyama K; Huang CL; Liu D; Okamoto T; Hayashi E; Yamamoto Y; Yokomise H
    J Thorac Cardiovasc Surg; 2002 Sep; 124(3):503-10. PubMed ID: 12202867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis.
    Maximus S; Nguyen DV; Mu Y; Calhoun RF; Cooke DT
    Am Surg; 2012 Nov; 78(11):1232-7. PubMed ID: 23089441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
    Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
    Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
    Fan Y; Du Y; Sun W; Wang H
    Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With N3 Disease.
    Shin JY; Yoon JK; Marwaha G
    Clin Lung Cancer; 2017 Nov; 18(6):e481-e489. PubMed ID: 28559200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.